Balyasny Asset Management
ALIM

Balyasny Asset Management’s Alimera Sciences ALIM Stock Holding History

Balyasny Asset Management’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,323
Closed -$40.3K – 3237
2024
Q1 		$40.3K Sell
10,323
-29,709
-74% -$113K ﹤0.01% 2530
2023
Q4 		$173K Buy
+40,032
New +$135K ﹤0.01% 2332
2015
Q3 		– Sell
-692
Closed -$48K – 1440
2015
Q2 		$48K Buy
+692
New +$47.7K ﹤0.01% 1105

Other funds holding ALIM

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Balyasny Asset Management's ALIM Position: Q2 2024 in Review

Balyasny Asset Management sold out of Alimera Sciences (ALIM) in Q2 2024, closing a stake of 10,323 shares — an estimated $40.3K sold.

Balyasny Asset Management first reported a position in ALIM in Q2 2015 and held it in 3 quarters. The position peaked at $173K in Q4 2023. 52 funds tracked by Wall St. Rank hold ALIM as of Q2 2024.

  • Balyasny Asset Management reported no remaining Alimera Sciences position as of Q2 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 10,323 Alimera Sciences shares in Q2 2024, an estimated $40.3K.
  • Balyasny Asset Management first reported a position in Alimera Sciences in Q2 2015 and held it in 3 quarters.
  • Balyasny Asset Management's Alimera Sciences position peaked at $173K in Q4 2023.
  • 52 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2024.

Based on Balyasny Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.